Dr. Elliot Regenbogen, MD

Dr. Regenbogen practices at New York Presbyterian Medical Center - Harkness Pavilion in New York, New York.

Dr. Regenbogen's NPI, 1659373058, was assigned on August 15, 2005. Dr. Regenbogen graduated from Albert Einstein College of Medicine in 1986. Dr. Regenbogen holds New York license 171320.

Dr. Regenbogen's primary practice is New York Presbyterian Medical Center - Harkness Pavilion, at 180 Ft Washington Ave, New York, NY 10032 in New York County. The practice phone is (212) 305-3174.

Dr. Regenbogen's primary practice is New York Presbyterian Medical Center - Harkness Pavilion in New York, New York. Dr. Regenbogen is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Regenbogen to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Regenbogen practices, 3 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Regenbogen's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Regenbogen is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dr. Regenbogen is licensed in New York.

Dmand AI lists acute sinusitis, chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery and hearing loss and impairment among the conditions Dr. Regenbogen treats.

CMS data shows 614 Medicare services from Dr. Regenbogen across 9 procedure codes in 2024, for 292 Medicare patients. Medicare paid $57,558 for them. Every service was in an office.

CMS counts 292 Medicare patients who saw Dr. Regenbogen in 2024. The largest group is 75 to 84, with 110 patients. 73% of them have high cholesterol, and 71% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Regenbogen's median patient age at 54, with 66% women.

In 2024, Dr. Regenbogen wrote 874 Medicare Part D claims for 264 patients. 98% of them were for generic drugs. CMS names the drug for 755 of them, across 11 drugs with 11 or more claims each, at $9,119 in total drug cost. In 2023, CMS named 620 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Regenbogen for performance year 2024, reported through an alternative payment model (APM). Dr. Regenbogen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Regenbogen as offering telehealth.

Dmand AI links 5 papers to Dr. Regenbogen, published from 2016 to 2018. Dr. Regenbogen's most frequent co-authors are Joseph Decristofaro, MD and Dana Alexa Telem, MD.

CMS Open Payments shows 12 general payments to Dr. Regenbogen from 6 drug and device companies from 2017 to 2024. Food and beverage make up the largest share, 100% of the total. Intersect ENT, Inc. paid the most, $255.

Dr. Regenbogen graduated from Albert Einstein College of Medicine in 1986.

Dr. Regenbogen is in network with 15 carriers, including United Healthcare, Aetna and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.